Dr. Christopher Dvorak is a specialist in stem cell transplantation for children with immunodeficiencies, blood disorders and cancer. He is chief of the UCSF Pediatric Allergy, Immunology and Bone Marrow Transplantation (BMT) Division and director of the Pediatric Cellular Therapy Laboratory.
In his research, Dvorak studies ways to lower the incidence of relapse in patients who have stem cell transplants for childhood leukemia. He also investigates how to minimize BMT complications and how to improve outcomes after stem cell transplants for severe combined immunodeficiencies (genetic disorders in which infants lack normal immune function), often called SCID.
Dvorak earned his medical degree at Vanderbilt University School of Medicine. He completed a residency in pediatrics as well as a fellowship in pediatric hematology, oncology and BMT at Stanford Medicine. Prior to joining UCSF in 2007, he was a clinical instructor for Stanford Medicine in the pediatric stem cell transplantation division
Dvorak is a national co-leader of the Primary Immune Deficiency Treatment Consortium, and he leads the Cancer Control and Supportive Care Committee for the Children's Oncology Group.